This document discusses functional hepatobiliary diseases, including chronic acalculous cholecystitis, gallbladder ejection fraction testing, and sphincter of Oddi dysfunction. It provides details on protocols for gallbladder ejection fraction testing using cholecystokinin cholescintigraphy or fatty meal stimulation. An abnormal ejection fraction below 35% may indicate gallbladder dyskinesia. Sphincter of Oddi dysfunction can cause post-cholecystectomy pain and be diagnosed using cholescintigraphy by detecting delayed biliary clearance after CCK administration. Therapies may include sphincterotomy or drugs to relax the sphincter of Oddi.
Nuclear medicine in biliary tract disordersRamin Sadeghi
In this presentation, application of nuclear medicine in biliary tract disorders is explained including cholecystitis, sphicter of Oddi dysfunction, neonatal cholestasis, biliary leak, etc.
Acute Cholecystitis, detailed management plan. conservative and surgical management, different surgical procedures, severity grading of acute cholecystitis, post operative management
Nuclear medicine in biliary tract disordersRamin Sadeghi
In this presentation, application of nuclear medicine in biliary tract disorders is explained including cholecystitis, sphicter of Oddi dysfunction, neonatal cholestasis, biliary leak, etc.
Acute Cholecystitis, detailed management plan. conservative and surgical management, different surgical procedures, severity grading of acute cholecystitis, post operative management
Call prep: emergency nuclear medicine proceduresHerbert Klein
Guidelines for radiology and nuclear medicine procedures taking call on nights and weekends: gastrointestinal bleeding, hepatobiliary and lung scans. It is interactive, e.g. using Keynote presentation software. PowerPoint
These presentation is related to biliary disorders. it is simple and concise presentation and provide all information about the biliary disease. i hope this presentation fulfill your requirements and should be useful.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Call prep: emergency nuclear medicine proceduresHerbert Klein
Guidelines for radiology and nuclear medicine procedures taking call on nights and weekends: gastrointestinal bleeding, hepatobiliary and lung scans. It is interactive, e.g. using Keynote presentation software. PowerPoint
These presentation is related to biliary disorders. it is simple and concise presentation and provide all information about the biliary disease. i hope this presentation fulfill your requirements and should be useful.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
3. Chronic Acalculus
Cholecystitis
relatively uncommon in comparison to
chronic calculous cholecystitis
RUQ pain and biliary colic, but have a
completely normal work-up, including
a normal ultrasound and hepatobiliary
study
4. Gallbladder Ejection Fraction
Abnormal gallbladder ejection
response to CCK : Patients with
chronically inflamed, partially
obstructed, or functionally impaired
gallbladders (gallbladder dyskinesia).
An abnormal gallbladder ejection
fraction is considered less than 35%
and is not affected by age
6. Routine cholescintigraphy:
1. The patient should have nothing by
mouth for 4 hours before the exam. If
fasting over 24 hours, the patient should
receive a slow infusion of CCK before
initiating the study. After CCK infusion, wait
30 min before radiopharmaceutical injection
to allow time for the gallbladder to relax.
2. Camera: Large field of view, anterior
projection
3. Computer set-up: 60 one minute frames
4. Patient set-up: Supine
5. Inject Tc-99m-mebrofenin or Tc-99m-
disofenin 5 mCi (185 MBq) I.V.
6. After the gallbladder has filled, usually at
60 minutes, commence setup for CCK
cholescintigraphy
7. CCK Cholescintigraphy:
1. Computer set-up: 30 one minute frames
2. Place camera in the left anterior oblique
projection to minimize overlap of gallbladder,
small bowel, and common duct activity.
3. Infuse 0.02 ug/kg sincalide diluted in a 30-mL
volume continuously over 30 minutes using a
constant infusion pump or volutrol for
intravenous rate control. Recently, a 60 minute
infusion has been suggested to provide more
consistent gallbladder contractility with imaging
and quantification over the entire 60 minute
period .
4. On the computer, draw a region of interest
around the gallbladder and adjacent liver
background.
5. Generate a gallbladder back-ground corrected
time-activity curve.
6. Calculate the percentage of gallbladder
8.
9.
10.
11.
12.
13.
14.
15. Rapid injection of Sincalide may cause
spasm of the cystic duct/gallbladder
neck which will impair emptying of the
gallbladder and falsely lower
gallbladder ejection fraction
abdominal cramping and nausea can
be seen in 50% of healthy subjects
16. An alternative to the use of sincalide is to
have the patient consume a fatty meal (at
least 10 gm of fat).
fatty meal ejection fractions can vary widely
(from 24% to 92%) and can be affected by
the meal content and the duration of imaging.
maximal gallbladder emptying is generally
seen 55 to 60 minutes following consumption
of the meal.
For a lactose-free Ensure Plus meal the
normal gallbladder ejection fraction is greater
than 33%
17. An abnormal gallbladder ejection fraction is
not necessarily diagnostic of chronic
cholecystitis. Chronic diseases such as
sprue, diabetes, achalasia, sickle cell
disease, and irritable bowel syndrome have
also been associated with a low GBEF.
Certain drugs can also falsely lower GBEF
including morphine, atropine, octreotide,
nifedipine, progesterone, and phentolamine.
It is very important to ensure that the patient
has not taken opioids during the 24 hours
prior to the exam as these agents can result
in a falsely decreased GBEF.
18.
19. Medications and Physiologic
States which can alter
gallbladder contractility:
Morphine: Produces spasm of the sphincter of Oddi.
Morphine has a 4 to 6 hour half-life, but approximately 50% of
patients who receive sincalide subsequent to having been
administered morphine during cholescintigraphy have normal
gallbladder contraction.
Atropine: Inhibits gallbladder emptying
Calcium channel blockers: Reduce contractility by interfering
with calcium mediated smooth muscle contraction
Diabetes: Neuropathy has been associated with decreasing
contractility
Truncal vagotomy: Results in decreased gallbladder
contractility and increased gallbladder volume due to
disruption of the cholinergic pathway.
Achalasia- decreases ejection fraction by 50%
Octreotide therapy
Cholinergic medications: Enhance gallbladder emptying
Hypercalcemia: Enhances contraction
20. Sphincter of Oddi Dyskinesia:
(Biliary Dyskinesia)
A functional disorder of the biliary tract
which is felt to be related to a
paradoxical response of the sphincter of
Oddi to CCK (Contraction rather than
relaxation). Patients complain of RUQ
pain and the disorder can be found in
both pre- and post cholecystectomy
patients.
On manometry, these patients are found
to have elevated sphincter of Oddi
pressures (over 20 mm Hg).
Treatment is sphincterotomy or
sphincteroplasty.
21. Scintigraphic findings in this
syndrome include delayed biliary-to-
bowel transit and a dilated common
duct sign (due to failure of the
sphincter of Oddi to relax) after CCK
administration.
Paradoxical filling of the gallbladder
following sincalide administration can
also be seen.
These patients, however, tend to have
a normal gallbladder ejection fraction.
22. Partial biliary obstruction after cholecystectomy. HIDA images at 1
hour (left) and 2 hours (right). At 1 hour considerable retained
activity in the common duct and proximal ducts is seen. At 2 hours,
the liver has cleared but, the common duct continues to retain
activity. This patient had sphincter of Oddi obstruction that required
subsequent sphincterotomy.
23. Sphincter of Oddi Dysfunction
Sphincter of Oddi dysfunction occurs in
approximately 10% of patients with the
postcholecystectomy pain syndrome.
It presents as intermittent abdominal pain and
sometimes transient liver function
abnormalities.
It is a partial biliary obstruction at the level of
the sphincter of Oddi, not caused by stones
or stricture.
It presents after cholecystectomy, possibly
because the gallbladder had been acting as a
pressure release valve, decompressing the
biliary ducts with increases in pressure,
preventing pain.
24. Patients have been classified clinically into 3
categories.
In type I, enzyme elevations are seen, with
pain episodes and dilated biliary ducts.
In type II, either enzyme elevations or dilated
biliary ducts occur.
Type III presents with only pain.
Patients with type I are the most easily
diagnosed.
Patients with types II and III are more
diagnostically challenging; cholescintigraphy
may have a role in these cases.
25. Therapy is usually sphincterotomy, particularly for a
fixed obstruction (papillary stenosis), whereas a
functional and reversible obstruction (biliary
dyskinesia) may temporarily respond to drugs (e.g.,
nifedipine) and toxins (e.g., Botox).
Sonography, CT, and MRCP often are not
diagnostic.
Sphincter of Oddi manometry has been regarded as
the gold standard, with an elevated sphincter
pressure (>40 mm Hg) being diagnostic. However,
this technique is invasive, not widely available,
technically difficult, prone to interpretative errors,
and associated with a significant incidence of
adverse effects, notably pancreatitis.
ERCP is ultimately used to exclude cholelithiasis or
stricture; however, it is invasive and associated with
a high Incidence of postprocedure complications,
26. The value of cholescintigraphy is
controversial. Evidence- based data are
lacking. However, multiple singlecenter
studies have shown it to be useful and is
routinely performed at some biliary
referral centers.
Early studies suggested that image
analysis alone can be diagnostic with
findings of a partial biliary obstruction—
that is, delayed biliary duct clearance at
60 minutes with no further clearance
between 1 and 2 hours